Data Points for the week of Dec. 14, 2015, covered the following topics: Mass shootings, healthcare costs, ebola, contraceptive coverage and breast cancer screening
Cheers erupted and people danced in the streets Saturday as Sierra Leone marked the end of the Ebola outbreak within its borders, although neighboring Guinea still struggles to stamp out the deadly virus that has killed more than 11,000 mostly in West Africa.
Leaders often talk about workplace culture, but it's hard to put a finger on what it means, or how it's developed.It comes from the people hired and the way they're treated, but it's also something leaders have to cultivate.
As public health officials continue to make connections between health and societal factors, there's mounting evidence that diseases once considered exotic are taking root in the poorest areas of the U.S.
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study being conducted in that nation's Kambia district, where some of the country's most recent Ebola cases have been reported.
In today's 24/7 media cycle, yesterday's news quickly fades as the press moves on to the next story. But sometimes those forgotten stories leave behind important unresolved issues. That's certainly the case with Ebola.
Hospital communication failure cited in review of care for Ebola patient Thomas Eric Duncan, and other news
The Texas hospital that treated the first person diagnosed in the U.S. with Ebola stumbled because of communication failures, an independent review released last week found.
The Texas hospital that treated the first person diagnosed in the U.S. with Ebola was not adequately prepared for a patient with the deadly virus and stumbled because of communication failures, an independent review released Friday found.
Eleven chimpanzees rushed out from the Liberian bush and descended from trees to the shore, making jubilant sounds to greet the speedboat bringing food.
The selection of U.S. Supreme Court Chief Justice John Roberts and President Barack Obama for the top two spots in the 14th annual Modern Healthcare 100 Most Influential People in Healthcare reflects the continuing centrality in healthcare of the ACA and the ongoing political battle over its future.
The threat of a looming “post-antibiotic era” has been detailed for years in media reports, but the Centers for Disease Control and Prevention says the nation has finally reached that tipping point.
Emergent BioSolutions announced plans Monday to develop and manufacture a treatment for the Ebola virus. The Maryland-based biopharmaceutical firm was awarded a federal contract valued at nearly $20 million.